Humaid Al-Shamsi Highlights AI Research in Tumor Biology and Resistance Mechanisms
Humaid Al-Shamsi/LinkedIn

Humaid Al-Shamsi Highlights AI Research in Tumor Biology and Resistance Mechanisms

Humaid Al-Shamsi, CEO of Burjeel Cancer Institute (BCI) Comprehensive Cancer Center, shared a post on LinkedIn:

“I was honored to be invited to deliver a lecture at the ‘distinguished lecturer‘ series at The Ohio State University and the Ohio State University Comprehensive Cancer Center-James Cancer Hospital, Solove Research Institute.

My lecture highlighted our ongoing research in using AI to decode tumor biology, identify mechanism of resistance and biomarker discovery.

I was impressed by the massive research, clinical infrastructure at the Ohio State University Comprehensive Cancer Center-James Cancer Hospital, Solove Research Institute under the leadership of Christian Rolfo, MD, PhD, MBA,Dr.hc , looking forward for strengthening our collaboration in cancer research to advance care care globally.”

Humaid Al-Shamsi

Other articles featuring Humaid Al-Shamsi on OncoDaily.